These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 33983909

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-N and anti-Doa immunoglobulin G alloantibody-mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with eculizumab and HBOC-201: case report and review of the literature.
    Unnikrishnan A, Pelletier JPR, Bari S, Zumberg M, Shahmohamadi A, Spiess BD, Michael MJ, Harris N, Harrell D, Mandernach MW.
    Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
    [Abstract] [Full Text] [Related]

  • 4. Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition.
    Vlachaki E, Gavriilaki E, Kafantari K, Adamidou D, Tsitsikas D, Chasapopoulou E, Anagnostopoulos A, Tsapas A.
    Hemoglobin; 2018 Jun; 42(5-6):339-341. PubMed ID: 30626228
    [Abstract] [Full Text] [Related]

  • 5. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP.
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [Abstract] [Full Text] [Related]

  • 6. Delayed hemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with beta-thalassemia: challenges in treatment.
    Hannema SE, Brand A, van Meurs A, Smiers FJ.
    Transfusion; 2010 Feb; 50(2):429-32. PubMed ID: 19788508
    [Abstract] [Full Text] [Related]

  • 7. Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment.
    Pirenne F, Bartolucci P, Habibi A.
    Transfus Clin Biol; 2017 Sep; 24(3):227-231. PubMed ID: 28669521
    [Abstract] [Full Text] [Related]

  • 8. An Unusual Case of Delayed Hemolytic Transfusion Reaction With Hyperhemolysis Syndrome Due to Anti-Jkb and Anti-Fya Alloantibodies.
    El Alaoui K, Benghiat FS, Colard M.
    J Hematol; 2022 Apr; 11(2):66-70. PubMed ID: 35573755
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report.
    Beck TN, Young NG, Erickson ML, Prats I.
    BMC Surg; 2017 Apr 26; 17(1):48. PubMed ID: 28441942
    [Abstract] [Full Text] [Related]

  • 11. Hyperhaemolytic transfusion reaction in two β-thalassaemia major patients: The role of eculizumab.
    Pantelidou D, Pilalas D, Daios S, Polychronopoulos G, Papadopoulou D, Perifanis V, Savopoulos C, Kaiafa G.
    J Clin Pharm Ther; 2022 Mar 26; 47(3):411-414. PubMed ID: 34397109
    [Abstract] [Full Text] [Related]

  • 12. Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab.
    Boonyasampant M, Weitz IC, Kay B, Boonchalermvichian C, Liebman HA, Shulman IA.
    Transfusion; 2015 Oct 26; 55(10):2398-403. PubMed ID: 25989361
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hyperhemolytic Syndrome Complicating a Delayed Hemolytic Transfusion Reaction due to anti-P1 Alloimmunization, in a Pregnant Woman with HbO-Arab/β-Thalassemia.
    Bezirgiannidou Z, Christoforidou A, Kontekaki E, Anastasiadis AG, Papamichos SI, Menexidou H, Margaritis D, Martinis G, Mantadakis E.
    Mediterr J Hematol Infect Dis; 2016 Oct 26; 8(1):e2016053. PubMed ID: 27872733
    [Abstract] [Full Text] [Related]

  • 16. A suspected delayed hemolytic transfusion reaction mediated by anti-Joa.
    Jajosky RP, Lumm WC, Wise SC, Bollag RJ, Shikle JF.
    Immunohematology; 2017 Jun 26; 33(2):73-75. PubMed ID: 28657766
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Three episodes of delayed hemolytic transfusion reactions due to multiple red cell antibodies, anti-Di, anti-Jk and anti-E.
    Yasuda H, Ohto H, Yamaguchi O, Sakuma S, Suzuki T, Mita M, Tsuneyama H, Uchikawa M.
    Transfus Sci; 2000 Oct 26; 23(2):107-12. PubMed ID: 11035271
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.